Biochemical aspects of the pathogenesis of amyotrophic lateral sclerosis
Zavalishin, I.A.; Khokhlov, A.P.; Larskiĭ, E.G.; Seĭfulla, R.D.; Roĭkhel', V.M.
Vestnik Akademii Meditsinskikh Nauk SSSR 12: 49-56
1988
ISSN/ISBN: 0002-3027 PMID: 3071018 Document Number: 307154
Document emailed within 1 workday
Related Documents
Abe, K. 2007: Pathogenesis and therapeutic perspectives for amyotrophic lateral sclerosis (ALS) Rinsho Shinkeigaku 47(11): 790-794Popova, L.M.; Morgunov, V.A. 1987: Pathogenesis and etiology of amyotrophic lateral sclerosis (clinico-morphological research) Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 87(12): 1761-1766
Simpson, E.P.; Mosier, D.; Appel, S.H. 2002: Mechanisms of disease pathogenesis in amyotrophic lateral sclerosis. a central role for calcium Advances in Neurology 88: 1-19
Lehmann, J. 1978: Clinical and pathological aspects of amyotrophic lateral sclerosis Neuropatologia Polska 16(1): 127-133
Mamoli, B. 1996: Medical intensive care aspects in treatment of amyotrophic lateral sclerosis Wiener Medizinische Wochenschrift 146(9-10): 188-190
Tienari, P.; Kiviharju, A.; Valori, M.; Lindholm, D.; Laaksovirta, H. 2016: The pathogenesis of amyotrophic lateral sclerosis and frontal lobe dementia is unraveling: pathology of the nucleus and glutamate sensitivity Duodecim; Laaketieteellinen Aikakauskirja 132(5): 423-431
Koufen, H.; Consbruch, U. 1970: The serum-creatine phosphokinase (CPK) activity in amyotrophic lateral sclerosis (ALS) and other neurogenous muscular atrophies with regard to differential diagnostic aspects Der Nervenarzt 41(12): 599-603
Alonso, K.; Medenica, R. 1995: Immunomodulation in the treatment of multiple sclerosis and amyotrophic lateral sclerosis: a model for autoimmune disorders Journal of the National Medical Association 87(8): 561-568
Gallagher, J.P. 1986: Is it amyotrophic lateral sclerosis or something else? Journal of the South Carolina Medical Association 82(1): 19-22
Zavalishin, I.A.; Zakharova, M.N. 1999: Amyotrophic lateral sclerosis Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 99(4): 60-64
1995: Riluzole for amyotrophic lateral sclerosis Medical Letter on Drugs and Therapeutics 37(963): 113-114
Bali, T.; Miller, T.M. 2013: Management of amyotrophic lateral sclerosis Missouri medicine 110(5): 417-421
Hirano, A. 1991: Cytopathology of amyotrophic lateral sclerosis Advances in Neurology 56: 91-101
Lupo, V.R.; Rusterholz, J.H.; Reichert, J.A.; Hanson, A.S. 1993: Amyotrophic lateral sclerosis in pregnancy Obstetrics and Gynecology 82(4 Pt 2(Suppl): 682-685
Antel, J.P.; Noronha, A.B.; Oger, J.J.; Arnason, B.G. 1982: Immunology of amyotrophic lateral sclerosis Advances in Neurology 36: 395-402
Vemireddi, N.K.; Crevoiserat, C.A. 1978: Amyotrophic lateral sclerosis in cancer Journal of the Mississippi State Medical Association 19(11): 201-204
Barkhatova, V.P.; Zavalishin, I.A.; Kostiuk, A.V.; Demina, E.G.; Moskvitina, T.A. 1996: Neurotransmitter changes in amyotrophic lateral sclerosis Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 96(4): 78-85
Kuźma-Kozakiewicz, M.; Kwieciński, H. 2009: The genetics of amyotrophic lateral sclerosis Neurologia i Neurochirurgia Polska 43(6): 538-549
Krutsay, M.; Jakubovits, E. 1993: Rapid course amyotrophic lateral sclerosis Orvosi Hetilap 134(40): 2209-2211
Kurtzke, J.F. 1982: Epidemiology of amyotrophic lateral sclerosis Advances in Neurology 36: 281-302